CompanyDrug

Luzhu Biotechnology’s Herpes Zoster Vaccine LZ901 Concludes Phase II Study

CompanyDrug

CMS Receives NMPA Approval for Tildrakizumab for Plaque Psoriasis Treatment

CompanyDeals

Cutia Therapeutics Lists on HKEX with HKD527 Million IPO for Dermatology Therapies

CompanyDrug

CSPC Pharmaceutical’s AlaMab Therapeutics Presents Positive ALMB-0168 Data at ASCO

CompanyDeals

Betta Pharmaceuticals Secures Exclusive Rights to C4 Therapeutics’ CFT8919 in Greater China

CompanyDeals

Lynk Pharmaceuticals Secures RMB 200 Million in Series C1 Financing Round

Policy / Regulatory

Digital China Development Report Highlights Growth of Digital Healthcare Ecosystem

CompanyDrug

BeiGene’s Brukinsa Receives Canadian Approval for Chronic Lymphocytic Leukemia

Company

Sanofi’s Commitment to China: Expansion, Digital Innovation, and Local R&D

CompanyDeals

XtalPi Partners with Eli Lilly for AI-Driven Drug Discovery Services

CompanyDrug

Chia Tai Tianqing’s Biosimilar Rituximab Approved by China’s NMPA for Lymphoma Treatments

CompanyDrug

Jiangsu Hengrui Pharmaceuticals Secures NMPA Approvals for SHR-2106 and HRS-1893 Clinical Trials